Innate Pharma S.A. (IPHA)

AI Score

Unlock

1.97

0.03 (1.55%)

At close: Apr 17, 2025, 3:51 PM

1.97

0.04%

After-hours: Apr 17, 2025, 05:58 PM EDT

Innate Pharma S.A. Balance Sheet Statement

Financials in EUR. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	70.61M	84.22M	103.76M	136.79M	202.89M	152.31M	99.37M	175.91M
Short-Term Investments	21.85M	17.26M	16.08M	14.85M	15.98M	15.22M	16.74M	21.78M
Long-Term Investments	9.8M	35.12M	39.88M	38.93M	37.01M	35.18M	60.47M	32.98M
Other Long-Term Assets	19.65M	14.25M	29.97M	30.09M	16.83M	87K	111K	355K
Receivables	15.23M	3.08M	846K	10.59M	2.82M	146.64M	15.08M	25.55M
Inventory	n/a	-2K	-4.95M	1.00	5.6M	1.00	6.33M	513K
Other Current Assets	34.63M	30.59M	14.99M	4.4M	10.52M	n/a	n/a	n/a
Total Current Assets	148.01M	139.83M	138.26M	173.33M	237.6M	319.64M	137.52M	230.08M
Property-Plant & Equipment	6.32M	8.54M	10.17M	11.69M	11.67M	10.22M	10.73M	9.09M
Goodwill & Intangibles	416K	1.56M	44.19M	46.29M	96.97M	84.53M	46.19M	9.07M
Total Long-Term Assets	36.18M	68.03M	129.24M	134.09M	163.76M	131.57M	117.5M	51.5M
Total Assets	184.19M	207.86M	267.5M	307.42M	401.36M	451.22M	255.02M	281.58M
Account Payables	8.56M	13.66M	14.73M	20.73M	27.94M	28.58M	19.97M	15.6M
Deferred Revenue	n/a	6.56M	12.5M	12.51M	48.77M	82.1M	47.91M	54.91M
Short-Term Debt	8.45M	1.26M	29.94M	1.36M	1.49M	394K	429K	375K
Other Current Liabilities	22.14M	19.02M	21.91M	22.61M	42.99M	71.62M	4.69M	4.67M
Total Current Liabilities	39.64M	41.34M	79.89M	46.69M	121.82M	196.74M	73.91M	76.44M
Long-Term Debt	30.61M	38.93M	11.49M	14.19M	14.1M	2.03M	2.42M	1.05M
Other Long-Term Liabilities	61.7M	55.74M	36.23M	49.25M	3.9M	14.4M	3.63M	112.35M
Total Long-Term Liabilities	92.66M	112.37M	80.17M	104.75M	62.12M	87.24M	95.16M	118.97M
Total Liabilities	132.29M	153.71M	160.06M	151.45M	183.94M	283.98M	169.07M	195.41M
Total Debt	39.89M	42.25M	44.25M	19.09M	18.72M	4.52M	5.86M	5.33M
Common Stock	4.04M	4.01M	3.98M	3.95M	3.94M	3.2M	2.88M	2.7M
Retained Earnings	-336.89M	-330.32M	-272.21M	-220.46M	-155.67M	-134.79M	-151.98M	-103.59M
Comprehensive Income	495K	819K	456K	355K	-472K	-1.1M	180K	-503K
Shareholders Equity	51.9M	54.15M	107.44M	155.97M	217.42M	167.24M	85.96M	86.17M
Total Investments	31.65M	52.38M	55.96M	53.78M	52.98M	35.18M	60.47M	32.98M